Ignite Creation Date:
2024-05-06 @ 3:20 PM
Last Modification Date:
2024-10-26 @ 1:48 PM
Study NCT ID:
NCT04603937
Status:
TERMINATED
Last Update Posted:
2023-10-02
First Post:
2020-10-21
Brief Title:
A Study to Evaluate the Efficacy Durability and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema DME
Sponsor:
Kodiak Sciences Inc
Organization:
Kodiak Sciences Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Diabetic Macular Edema |
Keywords:
| Name | View |
|---|---|
| DME | View |
| Kodiak | View |
| Vascular endothelial growth factor | View |
| Anti-VEGF | View |
| VEGF | View |
| Antibody biopolymer conjugate | View |
| Retinal Degeneration | View |
| Retinal Diseases | View |
| Eye Diseases | View |
| Vision Disorders | View |
| Vision low | View |
| Aflibercept | View |
| Eylea | View |
| Diabetes mellitus | View |
| Diabetes | View |
| Diabetic retinopathy | View |
| Macular edema | View |
| Diabetic macular edema | View |
| KSI-301 | View |